Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Reexamination Certificate
2011-06-28
2011-06-28
Huff, Sheela J (Department: 1643)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
C424S277100, C514S04400A
Reexamination Certificate
active
07968099
ABSTRACT:
A novel gene (designated 193P1E1B) and its encoded protein, and variants thereof, are described wherein 193P1E1B exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 193P1E1B provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 193P1E1B gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 191P1E1B can be used in active or passive immunization.
REFERENCES:
patent: 5643778 (1997-07-01), Nishikura
patent: 5840839 (1998-11-01), Wang et al.
patent: 1 308 459 (2003-05-01), None
patent: WO-98/39446 (1998-09-01), None
patent: WO-98/45435 (1998-10-01), None
patent: WO-99/06548 (1999-02-01), None
patent: WO-99/31236 (1999-06-01), None
patent: WO-99/38972 (1999-08-01), None
patent: WO-99/58675 (1999-11-01), None
patent: WO-00/18916 (2000-04-01), None
patent: WO-00/21991 (2000-04-01), None
patent: WO-01/12811 (2001-02-01), None
patent: WO-01/22920 (2001-04-01), None
patent: WO-01/42302 (2001-06-01), None
patent: WO-01/42451 (2001-06-01), None
patent: WO-01/60860 (2001-08-01), None
patent: WO-01/90157 (2001-11-01), None
patent: WO-02/29086 (2002-04-01), None
patent: WO-02/40718 (2002-05-01), None
patent: WO-02/48337 (2002-06-01), None
patent: WO-02/074961 (2002-09-01), None
patent: WO-02/085298 (2002-10-01), None
patent: WO-2004/028479 (2004-04-01), None
Alberts et al., Molecular Biology of the Cell, 3rd Edition (1994) p. 465.
Benjamini and Leskowitz, Immunology: A Short Course, Second Edition, John Wiley & Sons, Inc. (1993) Ch.3, pp. 37-45.
Boon, Adv. Can. Res. (1992) 58:177-210.
Bork, Genome Research (2000) 10:398-400.
Bork et al., Trends in Genetics (1996) 12:425-427.
Bowie et al., Science (1990) 247:1306-1310.
Brenner, Trends in Genetics (1999) 15:132-133.
Broder et al., Curr Opin Opin Biotechnol (2000) 11(6):581-585.
Bussenmakers et al., Cancer Res. (1999) 59:5975-5979.
Curti, Crit. Rev. in Oncology/Hematology (1993) 14:29-39.
Database EMBL, EBI accession No. EMBL:AK090584 (2002).
Database EMBL, EBI accession No. EMBL:AL519504 (2001).
Database EMBL, EBI accession No. EMBL:AL561096 (2001).
Database EMBL, EBI accession No. EMBL:BC013418 (2001).
Database EMBL, EBI accession No. EMBL:BG392826 (2001).
Doerks et al., Trends in Genetics (1998) 14:248-250.
Ezzell, J. NIH Res. (1995) 7:46-49.
Fu et al., EMBO Journal (1996) 15:4392-4401.
Greenbaum et al., Genome Biology (2003) 4(9):117.1-117.8.
Gura, Science (1997) 278:1041-1042.
Hubert et al., PNAS USA (1999) 96(25):14523-14528.
International Search Report for PCT/US02/39274, mailed on Oct. 6, 2004, 3 pages.
Jain, Sci. Am. (1994) 271:58-65.
Japanese Office Action for Application No. 2003-551277, mailed on Feb. 15, 2008, 7 pages.
Klein et al., Nature Medicine (1997) 3(4):402-408.
Lauritzsen et al., International Journal of Cancer (1998) 78:216-222.
McClean and Hill, Eur. J. of Cancer (1993) 29A:2243-2248.
NCBI Accession No. BC013418 (Sep. 4, 2001).
Office Action for European Patent Application No. EP 02 797 238.9, mailed on Jun. 13, 2008, 11 pages.
Ota et al., Nat. Genet. (2004) 36(1):40-45.
Sarma et al., Journal of Experimental Medicine (1999) 189:811-820.
Scott et al., Nature Genetics (1999) 21:440-443.
Shantz and Pegg, Int. J. of Biochem. and Cell Biol. (1999) 31:107-122.
Sherman et al., Critical Reviews in Immunol. (1998) 18(1-2):47-54.
Shibata et al., Genome Res. (2000) 10(11):1757-1771.
Skolnick et al., Trends in Biotech. (2000) 18:34-39.
Smith et al., Nature Biotechnology (1997) 15:1222-1223.
Spitler, Cancer Biotherapy (1995) 10:1-3.
Supplementary Partial European Search Report for EP 02797238.9, mailed Oct. 12, 2007, 7 pages.
Thai et al., Adv. Immunol. (2005) 86:113-136 (abstract only).
Wang et al., J. Biol. Chem. (1997) 272(35):22227-22235.
You et al., Neoplasia (2007) 9(6):464-470.
Japanese Office Action for Application No. 2003-551277, mailed on Aug. 4, 2009, 2 pages.
Inspection and Technique (2000) 28(5):509-512.
Challita-Eid Pia M.
Faris Mary
Ge Wangmao
Hubert Rene S.
Jakobovits Aya
Agensys, Inc.
Huff Sheela J
Morrison & Foerster / LLP
LandOfFree
Nucleic acid and corresponding protein entitled 193P1E1B... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acid and corresponding protein entitled 193P1E1B..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid and corresponding protein entitled 193P1E1B... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2628009